225 related articles for article (PubMed ID: 15660384)
21. microRNA expression in hepatitis B virus infected primary treeshrew hepatocytes and the independence of intracellular miR-122 level for de novo HBV infection in culture.
Xu G; Gao Z; He W; Ma Y; Feng X; Cai T; Lu F; Liu L; Li W
Virology; 2014 Jan; 448():247-54. PubMed ID: 24314655
[TBL] [Abstract][Full Text] [Related]
22. Are in vitro hepatitis B core promoter mutations important for clinical alterations in viral load?
Cheng Y; Seet BL; Ong CS; Wasser S; Tan TM; Peter FJ; Lim SG
Antiviral Res; 2006 Mar; 69(3):142-51. PubMed ID: 16406140
[TBL] [Abstract][Full Text] [Related]
23. A Quasi species of the pre-S/S gene and mutations of enhancer II/core promoter/pre-C in mothers and their children infected with hepatitis B virus via mother-to-infant transmission.
Xu H; Peng M; Qing Y; Ling N; Lan Y; Liang Z; Cai D; Li Y; Ren H
J Infect Dis; 2006 Jan; 193(1):88-97. PubMed ID: 16323136
[TBL] [Abstract][Full Text] [Related]
24. [Analysis of the relevance of the mutations of the precore and basic core promoter in HBV genome with the DNA amount of HBV viremia].
Kaijima H; Yukimasa N; Sugano E; Yasuhara T; Fukuchi K; Gomi K
Rinsho Byori; 2009 Apr; 57(4):332-7. PubMed ID: 19489434
[TBL] [Abstract][Full Text] [Related]
25. Fulminant hepatitis B associated with a specific insertion in the basal core promoter region of hepatitis B virus DNA after immunosuppressive treatment.
Gérolami R; Henry M; Borentain P; Colson P; Botta D; Tamalet C
Clin Infect Dis; 2005 Feb; 40(4):e24-7. PubMed ID: 15712066
[TBL] [Abstract][Full Text] [Related]
26. Role of glycosaminoglycans for binding and infection of hepatitis B virus.
Leistner CM; Gruen-Bernhard S; Glebe D
Cell Microbiol; 2008 Jan; 10(1):122-33. PubMed ID: 18086046
[TBL] [Abstract][Full Text] [Related]
27. Low frequency of mutations in the X gene, core promoter and precore region of hepatitis B virus infected Vietnamese.
Song LH; Duy DN; Binh VQ; Luty AJ; Kremsner PG; Bock CT
J Viral Hepat; 2005 Mar; 12(2):160-7. PubMed ID: 15720531
[TBL] [Abstract][Full Text] [Related]
28. Role of surface promoter mutations in hepatitis B surface antigen production and secretion in occult hepatitis B virus infection.
Sengupta S; Rehman S; Durgapal H; Acharya SK; Panda SK
J Med Virol; 2007 Mar; 79(3):220-8. PubMed ID: 17245717
[TBL] [Abstract][Full Text] [Related]
29. In vitro resistance to interferon-alpha of hepatitis B virus with basic core promoter double mutation.
Wang Y; Wei L; Jiang D; Cong X; Fei R; Chen H; Xiao J; Wang Y
Antiviral Res; 2007 Aug; 75(2):139-45. PubMed ID: 17397939
[TBL] [Abstract][Full Text] [Related]
30. Stable HepG2- and Huh7-based human hepatoma cell lines for efficient regulated expression of infectious hepatitis B virus.
Sun D; Nassal M
J Hepatol; 2006 Nov; 45(5):636-45. PubMed ID: 16935386
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis B virus genotyping, core promoter, and precore/core mutations among Afghan patients infected with hepatitis B: a preliminary report.
Amini-Bavil-Olyaee S; Alavian SM; Adeli A; Sarrami-Forooshani R; Sabahi F; Sabouri E; Tavangar HR; Azizi M; Mahboudi F
J Med Virol; 2006 Mar; 78(3):358-64. PubMed ID: 16419114
[TBL] [Abstract][Full Text] [Related]
32. Presence of hepatitis B virus core promoter mutations pre-seroconversion predict persistent viral replication after HBeAg loss.
Ferns RB; Naoumov NV; Gilson RJ; Tedder RS
J Clin Virol; 2007 Jul; 39(3):199-204. PubMed ID: 17526429
[TBL] [Abstract][Full Text] [Related]
33. Association of core promoter mutations with viral breakthrough in chronic hepatitis B patients on long-term lamivudine therapy.
Kazim SN; Chauhan R; Das BC; Sarin SK
J Gastroenterol Hepatol; 2006 Oct; 21(10):1525-32. PubMed ID: 16928212
[TBL] [Abstract][Full Text] [Related]
34. Genetic dissection of naturally occurring basal core promoter mutations of hepatitis B virus reveals a silent phenotype in the overlapping X gene.
Hussain Z; Jung HS; Ryu DK; Ryu WS
J Gen Virol; 2009 Sep; 90(Pt 9):2272-81. PubMed ID: 19439550
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B virus sensitizes hepatocytes to complement-dependent cytotoxicity through downregulating CD59.
Qu Z; Liang X; Liu Y; Du J; Liu S; Sun W
Mol Immunol; 2009 Dec; 47(2-3):283-9. PubMed ID: 19804910
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of hepatitis B virus subgenotypes and basal core promoter, precore variants in patients with acute hepatitis B in central Vietnam.
Hayashi K; Katano Y; Chuong TX; Takeda Y; Ishigami M; Itoh A; Hirooka Y; Nakano I; Huy TV; Minh NN; Diem Tt; An Dt; Phiet PH; Goto H
Intervirology; 2009; 52(1):22-8. PubMed ID: 19349715
[TBL] [Abstract][Full Text] [Related]
37. Functional analysis of hepatitis B virus reactivating in hepatitis B surface antigen-negative individuals.
Hass M; Hannoun C; Kalinina T; Sommer G; Manegold C; Günther S
Hepatology; 2005 Jul; 42(1):93-103. PubMed ID: 15962285
[TBL] [Abstract][Full Text] [Related]
38. Community-based epidemiology of hepatitis B virus infection in West Bengal, India: prevalence of hepatitis B e antigen-negative infection and associated viral variants.
Chowdhury A; Santra A; Chakravorty R; Banerji A; Pal S; Dhali GK; Datta S; Banerji S; Manna B; Chowdhury SR; Bhattacharya SK; Mazumder DG
J Gastroenterol Hepatol; 2005 Nov; 20(11):1712-20. PubMed ID: 16246191
[TBL] [Abstract][Full Text] [Related]
39. CREB/PKA sensitive signalling pathways activate and maintain expression levels of the hepatitis B virus pre-S2/S promoter.
Tacke F; Liedtke C; Bocklage S; Manns MP; Trautwein C
Gut; 2005 Sep; 54(9):1309-17. PubMed ID: 15871998
[TBL] [Abstract][Full Text] [Related]
40. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.
Elkady A; Tanaka Y; Kurbanov F; Oynsuren T; Mizokami M
J Gastroenterol Hepatol; 2008 Mar; 23(3):474-81. PubMed ID: 18318825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
